Alvarez receives 2017 Marsh O’Neill Award
Mike Alvarez, the animal care supervisor in the Veterinary Service Center, received the 2017 Marsh O’Neill award. The award is one of the few opportunities for faculty to acknowledge publicly the support of outstanding staff members who support their research activity.
New children's hospital opens Dec. 9
The expansion more than doubles the size of the existing pediatric and obstetric hospital campus. With the new building, the hospital will have 361 beds and can serve more patients than ever before.
Faculty get funding from stem cell agency
Three Stanford faculty members were awarded $6 million to support research into a blistering skin disease, transplanted stem cells and novel ways to grow blood stem cells.
Mello on clinical trial reporting
A Stanford professor of law and of health policy discusses the ranking of large pharmaceutical companies based on their sharing of clinical trial information with the public.
Faculty members appointed to endowed professorships
Daniel Chang, Howard Chang, Christopher Garcia, Amy Ladd, William Maloney, Geoffrey Tabin and Jerome Yesavage have been appointed to endowed professorships at the School of Medicine.
Male health condition linked to new risk
Harnessing the power of big data, Stanford researchers found that enlarged veins on the scrotum are linked with a higher risk of vascular and metabolic disease in men.
Stem cells for fat have circadian clock
New discoveries about the circadian-clock machinery in the precursors to fat cells may explain why shift workers are prone to metabolic diseases, such as diabetes, a Stanford study finds.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
‘Drugs’ from gut bugs
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.
Possible new cell therapy for leukemia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Magazine focuses on kids
The magazine’s fall issue highlights the ways specialists are using the latest technology and treatments to put children and their families at the center of care. It also includes an inside peek at the new Packard Children’s Hospital.
Ex-49er returns to Stanford to finish residency
A series of fortunate events eventually brought successful medical device entrepreneur Milt McColl, MD, back to his original mission — clinical medicine.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.